Concepedia

A. Arkhipov

AA

Statistics

Publications

3

Citations

175

H-Index

3

Active since

1999

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Sheba Medical Center

Ministry of Health of the Russian Federation

A. Arkhipov is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in obstetrics, gynecology oncology, and oncology.

Top concepts

Publications per year

1999–2024

3

Publications

3

Multicenter, Phase II Trial of Exemestane as Third-Line Hormonal Therapy of Postmenopausal Women With Metastatic Breast Cancer

Stefanie A Jones, Charles L. Vogel, A. Arkhipov et al. · Journal of Clinical Oncology · 1999 · 113 citations

Pembrolizumab plus chemotherapy for advanced and recurrent cervical cancer: final analysis according to bevacizumab use in the randomized KEYNOTE-826 study

D. Lorusso, Nicoletta Colombo, Coraline Dubot et al. · Annals of Oncology · 2024 · 34 citations · Full text

, , +11

Pembrolizumab in patients with MSI-H advanced endometrial cancer from the KEYNOTE-158 study

David M. O’Malley, Aurélien Marabelle, Ana De Jesus‐Acosta et al. · Annals of Oncology · 2019 · 28 citations · Full text

, , +5

1–3 of 3